CRBP III inhibitors constitute a specialized class of chemicals designed to modulate the activity of Cellular Retinol-Binding Protein III (CRBP III). CRBP III is a member of the CRBP family, which plays a pivotal role in the intracellular transport and metabolism of retinoids, including retinol (vitamin A) and its derivatives. This protein binds retinoids with high affinity, facilitating their transport to various cellular compartments where they are metabolized or utilized in different biochemical pathways. CRBP III is specifically involved in the handling of retinoids in tissues such as the liver and eye, contributing to the regulation of retinoid homeostasis and cellular functions linked to vision and cellular differentiation.
Inhibitors of CRBP III typically interact with the protein in a manner that prevents it from binding to retinoids or alters its ability to shuttle these molecules effectively within the cell. These inhibitors can include small organic molecules, peptides, or other chemical entities that are engineered to disrupt the binding interactions between CRBP III and its retinoid ligands. By obstructing these interactions, CRBP III inhibitors can affect the availability and distribution of retinoids, thus influencing the associated biochemical and physiological processes. The study of CRBP III inhibitors provides valuable insights into the role of retinoids in cellular processes and the ways in which modulating their transport can impact cellular functions and homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
All-trans Retinoic Acid may initiate a negative feedback loop that specifically downregulates CRBP III expression to maintain homeostasis in retinoid metabolism. | ||||||
Citral | 5392-40-5 | sc-252620 | 1 kg | $212.00 | ||
Citral has the potential to interfere with retinoid absorption and storage, thereby decreasing CRBP III expression by creating a deficit of intracellular retinol. | ||||||
13-cis-Retinoic acid | 4759-48-2 | sc-205568 sc-205568A | 100 mg 250 mg | $75.00 $120.00 | 8 | |
13-cis-Retinoic acid, by mimicking retinol's biological activity, might lead to the downregulation of CRBP III as the cell attempts to reduce excess retinoid levels. | ||||||
Acitretin | 55079-83-9 | sc-210754 | 25 mg | $151.00 | 1 | |
Acitretin could reduce CRBP III expression by acting as a potent retinoid that disrupts the normal feedback and storage mechanisms of retinol and its derivatives. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
Ketoconazole can inhibit steroid synthesis, which may lead to a downstream decrease in CRBP III expression due to altered steroidal regulation of gene expression. | ||||||
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
Bisphenol A's estrogen-like activity could disrupt the hormonal balance, leading to a decrease in CRBP III expression via estrogen receptor-mediated pathways. | ||||||
Lead(II) Acetate | 301-04-2 | sc-507473 | 5 g | $85.00 | ||
Lead exposure is known to disrupt various biological pathways, potentially leading to a reduction in CRBP III expression by interfering with gene transcription mechanisms. | ||||||
Cadmium chloride, anhydrous | 10108-64-2 | sc-252533 sc-252533A sc-252533B | 10 g 50 g 500 g | $56.00 $183.00 $352.00 | 1 | |
Cadmium's ability to mimic hormonal activity could result in the downregulation of CRBP III expression through interference with hormone-responsive signaling pathways. | ||||||
Arsenic(III) oxide | 1327-53-3 | sc-210837 sc-210837A | 250 g 1 kg | $89.00 $228.00 | ||
Arsenic trioxide may inhibit CRBP III expression by disrupting specific transcription factors and signaling pathways that are essential for the maintenance of normal retinoid function. | ||||||